In vivo models in breast cancer research: progress, challenges and future directions

Ingunn Holen, Valerie Speirs, Bethny Morrissey, Karen Blyth

Research output: Contribution to journalReview article

24 Citations (Scopus)
5 Downloads (Pure)

Abstract

Research using animal model systems has been instrumental in delivering improved therapies for breast cancer, as well as in generating new insights into the mechanisms that underpin development of the disease. A large number of different models are now available, reflecting different types and stages of the disease; choosing which one to use depends on the specific research question(s) to be investigated. Based on presentations and discussions from leading experts who attended a recent workshop focused on in vivo models of breast cancer, this article provides a perspective on the many varied uses of these models in breast cancer research, their strengths, associated challenges and future directions. Among the questions discussed were: how well do models represent the different stages of human disease; how can we model the involvement of the human immune system and microenvironment in breast cancer; what are the appropriate models of metastatic disease; can we use models to carry out preclinical drug trials and identify pathways responsible for drug resistance; and what are the limitations of patient-derived xenograft models? We briefly outline the areas where the existing breast cancer models require improvement in light of the increased understanding of the disease process, reflecting the drive towards more personalised therapies and identification of mechanisms of drug resistance.

Original languageEnglish
Pages (from-to)359-371
Number of pages13
JournalDisease Models & Mechanisms
Volume10
Issue number4
DOIs
Publication statusPublished - 1 Apr 2017

Fingerprint

Breast Neoplasms
Research
Drug Resistance
Heterografts
Immune System
Animal Models
Direction compound
Pharmaceutical Preparations
Education
Immune system
Therapeutics
Animals

Keywords

  • Animals
  • Biomedical Research
  • Breast Neoplasms
  • Disease Models, Animal
  • Drug Resistance, Neoplasm
  • Female
  • Genetic Engineering
  • Humans
  • Molecular Targeted Therapy
  • Journal Article
  • Review
  • Research Support, Non-U.S. Gov't

Cite this

In vivo models in breast cancer research : progress, challenges and future directions. / Holen, Ingunn; Speirs, Valerie; Morrissey, Bethny; Blyth, Karen.

In: Disease Models & Mechanisms, Vol. 10, No. 4, 01.04.2017, p. 359-371.

Research output: Contribution to journalReview article

Holen, Ingunn ; Speirs, Valerie ; Morrissey, Bethny ; Blyth, Karen. / In vivo models in breast cancer research : progress, challenges and future directions. In: Disease Models & Mechanisms. 2017 ; Vol. 10, No. 4. pp. 359-371.
@article{52ad65868d0542758c47afd7660c9614,
title = "In vivo models in breast cancer research: progress, challenges and future directions",
abstract = "Research using animal model systems has been instrumental in delivering improved therapies for breast cancer, as well as in generating new insights into the mechanisms that underpin development of the disease. A large number of different models are now available, reflecting different types and stages of the disease; choosing which one to use depends on the specific research question(s) to be investigated. Based on presentations and discussions from leading experts who attended a recent workshop focused on in vivo models of breast cancer, this article provides a perspective on the many varied uses of these models in breast cancer research, their strengths, associated challenges and future directions. Among the questions discussed were: how well do models represent the different stages of human disease; how can we model the involvement of the human immune system and microenvironment in breast cancer; what are the appropriate models of metastatic disease; can we use models to carry out preclinical drug trials and identify pathways responsible for drug resistance; and what are the limitations of patient-derived xenograft models? We briefly outline the areas where the existing breast cancer models require improvement in light of the increased understanding of the disease process, reflecting the drive towards more personalised therapies and identification of mechanisms of drug resistance.",
keywords = "Animals, Biomedical Research, Breast Neoplasms, Disease Models, Animal, Drug Resistance, Neoplasm, Female, Genetic Engineering, Humans, Molecular Targeted Therapy, Journal Article, Review, Research Support, Non-U.S. Gov't",
author = "Ingunn Holen and Valerie Speirs and Bethny Morrissey and Karen Blyth",
note = "SEARCHBreast was funded by an Infrastructure for Impact grant from the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), UK (NC/L001004/1). Work in the corresponding author's lab is funded by Cancer Research UK (C596/A17196).",
year = "2017",
month = "4",
day = "1",
doi = "10.1242/dmm.028274",
language = "English",
volume = "10",
pages = "359--371",
journal = "Disease Models & Mechanisms",
issn = "1754-8403",
publisher = "Company of Biologists Ltd",
number = "4",

}

TY - JOUR

T1 - In vivo models in breast cancer research

T2 - progress, challenges and future directions

AU - Holen, Ingunn

AU - Speirs, Valerie

AU - Morrissey, Bethny

AU - Blyth, Karen

N1 - SEARCHBreast was funded by an Infrastructure for Impact grant from the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), UK (NC/L001004/1). Work in the corresponding author's lab is funded by Cancer Research UK (C596/A17196).

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Research using animal model systems has been instrumental in delivering improved therapies for breast cancer, as well as in generating new insights into the mechanisms that underpin development of the disease. A large number of different models are now available, reflecting different types and stages of the disease; choosing which one to use depends on the specific research question(s) to be investigated. Based on presentations and discussions from leading experts who attended a recent workshop focused on in vivo models of breast cancer, this article provides a perspective on the many varied uses of these models in breast cancer research, their strengths, associated challenges and future directions. Among the questions discussed were: how well do models represent the different stages of human disease; how can we model the involvement of the human immune system and microenvironment in breast cancer; what are the appropriate models of metastatic disease; can we use models to carry out preclinical drug trials and identify pathways responsible for drug resistance; and what are the limitations of patient-derived xenograft models? We briefly outline the areas where the existing breast cancer models require improvement in light of the increased understanding of the disease process, reflecting the drive towards more personalised therapies and identification of mechanisms of drug resistance.

AB - Research using animal model systems has been instrumental in delivering improved therapies for breast cancer, as well as in generating new insights into the mechanisms that underpin development of the disease. A large number of different models are now available, reflecting different types and stages of the disease; choosing which one to use depends on the specific research question(s) to be investigated. Based on presentations and discussions from leading experts who attended a recent workshop focused on in vivo models of breast cancer, this article provides a perspective on the many varied uses of these models in breast cancer research, their strengths, associated challenges and future directions. Among the questions discussed were: how well do models represent the different stages of human disease; how can we model the involvement of the human immune system and microenvironment in breast cancer; what are the appropriate models of metastatic disease; can we use models to carry out preclinical drug trials and identify pathways responsible for drug resistance; and what are the limitations of patient-derived xenograft models? We briefly outline the areas where the existing breast cancer models require improvement in light of the increased understanding of the disease process, reflecting the drive towards more personalised therapies and identification of mechanisms of drug resistance.

KW - Animals

KW - Biomedical Research

KW - Breast Neoplasms

KW - Disease Models, Animal

KW - Drug Resistance, Neoplasm

KW - Female

KW - Genetic Engineering

KW - Humans

KW - Molecular Targeted Therapy

KW - Journal Article

KW - Review

KW - Research Support, Non-U.S. Gov't

U2 - 10.1242/dmm.028274

DO - 10.1242/dmm.028274

M3 - Review article

C2 - 28381598

VL - 10

SP - 359

EP - 371

JO - Disease Models & Mechanisms

JF - Disease Models & Mechanisms

SN - 1754-8403

IS - 4

ER -